Clinical Trial Update: Study of AV-1959D, an Amyloid Beta Vaccine [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating AV-1959D, an amyloid beta vaccine, for Alzheimer's disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AV-1959D

Snippet

Sponsor: Institute for Molecular Medicine | Conditions: Alzheimer Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING